Increasing utility of FeNO as a biomarker of type-2 inflammation in severe asthma. (2021)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00170-3
PubMed Identifier: 34181878
Publication URI: http://europepmc.org/abstract/MED/34181878
Type: Journal Article/Review
Volume: 9
Parent Publication: The Lancet. Respiratory medicine
Issue: 10
ISSN: 2213-2600